In 2022, the Association for Regenerative Medicine (ARM) reported that over 2,000 clinical trials employed cell therapy, cell-based immuno-oncology, gene therapy, or tissue engineering. The cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback